Jan Schellens
Chief Medical Officer
Oncology
Modra Pharmaceuticals
Netherlands
Biography
Jan Schellens is co-founder of Modra Pharmaceuticals and is responsible for medical and clinical management. He is medical oncologist, clinical pharmacologist, head of the Department of Clinical Pharmacology (GCP-licensed) of the NKI-AvL, and Professor of Clinical Pharmacology at Utrecht University in the Netherlands. Jan Schellens has authored more than 750 scientific publications. He has more than 20 years of experience in clinical drug research and over 15 years of experience in drug regulation as member of the Dutch Medicines Evaluation Board (CBG-MEB). He was member of the Scientific Advisory Group Oncology to the European Medicines Agency for 12 years, and was Chair between 2006 - 2012. Jan is an advisor to many pharmaceutical companies including AstraZeneca, Astex, Merck, Pfizer, Roche, Eisai and Clovis Pharma.
Research Interest
Oncology
